1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Spinal Surgery Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Spinal Surgery Market, United States
3.1 Spinal Surgery Market, United States, Revenue ($m), 2015-2025
3.1.1 Minimal Invasive Spinal Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Spinal Fusion Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Spinal Non-Fusion Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.4 Vertebral Body Replacement Systems Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.5 Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Spinal Surgery Market, United States, Volume (Units), 2015-2025
3.2.1 Minimal Invasive Spinal Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Spinal Fusion Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Spinal Non-Fusion Market, United States, Volume (Units), by Segment, 2015-2025
3.2.4 Vertebral Body Replacement Systems Market, United States, Volume (Units), by Segment, 2015-2025
3.2.5 Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Spinal Surgery Market, United States, Average Price ($) , 2015-2025
3.4 Spinal Surgery Market, United States, Distribution Share by Revenue ($m), 2019
3.5 Spinal Surgery Market, United States, Company Share by Revenue ($m), 2019
4 Overview of Key Companies in United States, Spinal Surgery Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 DePuy Synthes Inc
4.2.1 Company Overview
4.3 Stryker Corp
4.3.1 Company Overview
4.4 NuVasive Inc
4.4.1 Company Overview
4.5 Globus Medical Inc
4.5.1 Company Overview
4.6 Zimmer Biomet Holdings Inc
4.6.1 Company Overview
5 Spinal Surgery Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Pantheon Spinal Acquires Incite Innovation
6.2 Debt Offerings
6.2.1 Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023
6.2.2 CryoLife Prices Private Placement of 4.250% Notes Due 2025 for USD100 Million
6.2.3 NuVasive Raises USD450 Million in Private Placement of 1% Convertible Senior Notes Due 2023
6.2.4 Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025
6.2.5 Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030
6.2.6 Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050
6.2.7 Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million
6.2.8 Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million
6.2.9 NuVasive Prices Private Placement of 0.375% Notes Due 2025 for USD450 Million
6.3 Equity Offerings
6.3.1 InVivo Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants
6.3.2 Alphatec Holdings Raises USD115 Million in Public Offering of Shares
6.3.3 Spinal Elements to Raise up to USD115.5 Million in IPO of Shares
6.3.4 SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities
6.3.5 CryoLife Raises USD20 Million in Equity Financing
6.3.6 SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares
6.3.7 SINTX Technologies Prices Private Placement of Shares for USD3 Million
6.3.8 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares
6.3.9 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million
6.3.10 OrthoPediatrics Raises USD75.2 Million in Public Offering of Shares
6.3.11 InVivo Therapeutics Raises USD3 Million in Private Placement of Shares
6.3.12 InVivo Therapeutics Raises USD7 Million in Public Offering of Shares and Warrants
6.3.13 DiscGenics to Raise Funds through Private Placement
6.3.14 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock
6.3.15 Aurora Spine Raises USD0.2 Million in Equity Offering
6.3.16 Sintx Technologies to Raise USD8.8 million in Rights Offering
6.4 Grants
6.4.1 Novel Test of Infant Hearing
6.4.2 IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy
6.5 Partnerships
6.5.1 Orthofix Medical and Neo Medical Enter into Partnership
6.6 Private Equity
6.6.1 Alphatec to Raise USD138 Million in Private Placement of Common Stock
6.6.2 MiMedx to Raise USD100 Million in Private Equity Financing
6.7 Venture Financing
6.7.1 ReGelTec Raises USD3.75 Million in Venture Funding
6.7.2 DiscGenics Raises USD4 Million in Series A Financing
6.7.3 DiscGenics Raises USD50 Million in Series C Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference
7.1.2 Mar 02, 2020: Stryker announces new Investor Relations leader
7.1.3 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
7.1.4 Feb 10, 2020: Roche’s gantenerumab fails in Phase II/III inherited Alzheimer’s trial
7.1.5 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
7.2 Financial Announcements
7.2.1 Feb 20, 2020: LX Analyzer successfully detects Coronavirus RNA
7.2.2 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance
7.2.3 Feb 13, 2020: CryoLife reports fourth quarter and full year 2019 financial results
7.2.4 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020
7.2.5 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results
7.2.6 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance
7.2.7 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
7.3 Government and Public Interest
7.3.1 Nov 18, 2020: OnPoint Surgical to participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum
7.3.2 Aug 27, 2020: SANUWAVE Health to Participate in Upcoming September Investor Conferences
7.4 Legal And Regulatory
7.4.1 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures
7.4.2 Mar 05, 2020: U.S. Attorney sues spinal device company and its executives for allegations that they paid kickbacks to surgeons
7.4.3 Mar 05, 2020: DOJ files suit against spine device manufacturer and executives alleging kickbacks to surgeons through sham consulting payments
7.4.4 Feb 14, 2020: SpineGuard initiates safeguard proceedings while adapting its governance to strengthen the development of innovation
7.5 Other Significant Developments
7.5.1 Aug 11, 2020: ICM Brain and Spine Institute selects Western Digital OpenFlex solution to speed up time to discovery of critical cures and treatment options
7.5.2 Aug 03, 2020: Hyaluronic acid provides knee oa pain relief with lower costs, fewer adverse outcomes vs. corticosteroids or knee arthroplasty
7.5.3 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
7.5.4 May 28, 2020: Conformis announces settlement of patent dispute
7.5.5 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol
7.6 Product News
7.6.1 Dec 15, 2020: HSS bone study sheds light on complications after spinal surgery
7.6.2 Oct 06, 2020: ATEC announces commercial release of distinct, comprehensive TLIF approach
7.6.3 Oct 05, 2020: Aurora Spine’s patent related to DEXA technology patient-matched implant technology issued by the United States Patent Office
7.6.4 Aug 26, 2020: Promimic’s business partner launches unique 3D-printed implants following FDA approval
7.6.5 Jun 18, 2020: Spinal Elements lunches platform to reduce spine surgery consequences
7.6.6 Jun 17, 2020: Spinal Elements introduces its MIS Ultra platform of products and procedures designed to minimize the unintended consequences of spine surgery
7.6.7 Jun 15, 2020: Study finds similar short-term outcomes after two common minimally invasive spine procedures
7.6.8 Apr 27, 2020: SpineGuard strengthens its IP with the grant of three new patents
7.7 Strategy And Business Planning
7.7.1 Jan 15, 2021: OrthoPediatrics expands its agent network in three strategic European countries
7.7.2 Aug 06, 2020: WishBone Medical acquires two firms to expand sterile spine product range
7.7.3 Jan 27, 2020: Spine Care Technologies and Zober Industries announce Strategic Alliance
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer

List of Tables
Table 1: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Minimal Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Minimal Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 12: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 13: Spinal Surgery Market, United States, Volume (Units), 2015-2020
Table 14: Spinal Surgery Market, United States, Volume (Units), 2021-2025
Table 15: Minimal Invasive Spinal Devices Market, United States, Volume (Units), 2015-2020
Table 16: Minimal Invasive Spinal Devices Market, United States, Volume (Units), 2021-2025
Table 17: Spinal Fusion Market, United States, Volume (Units), 2015-2020
Table 18: Spinal Fusion Market, United States, Volume (Units), 2021-2025
Table 19: Spinal Non-Fusion Market, United States, Volume (Units), 2015-2020
Table 20: Spinal Non-Fusion Market, United States, Volume (Units), 2021-2025
Table 21: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2015-2020
Table 22: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2021-2025
Table 23: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2015-2020
Table 24: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2021-2025
Table 25: Spinal Surgery Market, United States, Average Price ($), 2015-2020
Table 26: Spinal Surgery Market, United States, Average Price ($), 2021-2025
Table 27: Spinal Surgery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 28: Spinal Surgery Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 29: Spinal Surgery Market Pipeline Products
Table 30: Pantheon Spinal Acquires Incite Innovation
Table 31: Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023
Table 32: CryoLife Prices Private Placement of 4.250% Notes Due 2025 for USD100 Million
Table 33: NuVasive Raises USD450 Million in Private Placement of 1% Convertible Senior Notes Due 2023
Table 34: Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025
Table 35: Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030
Table 36: Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050
Table 37: Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million
Table 38: Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million
Table 39: NuVasive Prices Private Placement of 0.375% Notes Due 2025 for USD450 Million
Table 40: InVivo Therapeutics Raises USD15 Million in Public Offering of Shares and Warrants
Table 41: Alphatec Holdings Raises USD115 Million in Public Offering of Shares
Table 42: Spinal Elements to Raise up to USD115.5 Million in IPO of Shares
Table 43: SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities
Table 44: CryoLife Raises USD20 Million in Equity Financing
Table 45: SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares
Table 46: SINTX Technologies Prices Private Placement of Shares for USD3 Million
Table 47: SINTX Technologies to Raise USD41.3 Million in Public offering of Shares
Table 48: SINTX Technologies Prices Private Placement of Shares for USD5.6 Million
Table 49: OrthoPediatrics Raises USD75.2 Million in Public Offering of Shares
Table 50: InVivo Therapeutics Raises USD3 Million in Private Placement of Shares
Table 51: InVivo Therapeutics Raises USD7 Million in Public Offering of Shares and Warrants
Table 52: DiscGenics to Raise Funds through Private Placement
Table 53: SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock
Table 54: Aurora Spine Raises USD0.2 Million in Equity Offering
Table 55: Sintx Technologies to Raise USD8.8 million in Rights Offering
Table 56: Novel Test of Infant Hearing
Table 57: IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy
Table 58: Orthofix Medical and Neo Medical Enter into Partnership
Table 59: Alphatec to Raise USD138 Million in Private Placement of Common Stock
Table 60: MiMedx to Raise USD100 Million in Private Equity Financing
Table 61: ReGelTec Raises USD3.75 Million in Venture Funding
Table 62: DiscGenics Raises USD4 Million in Series A Financing
Table 63: DiscGenics Raises USD50 Million in Series C Financing
Table 64: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures
Figure 1: Spinal Surgery Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Minimal Invasive Spinal Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Spinal Fusion Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Spinal Non-Fusion Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Vertebral Body Replacement Systems Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 6: Vertebral Compression Fracture Repair Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 7: Spinal Surgery Market, United States, Volume (Units), 2015-2025
Figure 8: Minimal Invasive Spinal Devices Market, United States, Volume (Units), 2015-2025
Figure 9: Spinal Fusion Market, United States, Volume (Units), 2015-2025
Figure 10: Spinal Non-Fusion Market, United States, Volume (Units), 2015-2025
Figure 11: Vertebral Body Replacement Systems Market, United States, Volume (Units), 2015-2025
Figure 12: Vertebral Compression Fracture Repair Devices Market, United States, Volume (Units), 2015-2025
Figure 13: Spinal Surgery Market, United States, Company Share (%) 2019